Basics |
Company: |
Corbus Pharmaceuticals Holdings, Inc. Common Stock |
IPO Date: |
November 1, 2014 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$103.65M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.31 | 3.90%
|
Avg Daily Range (30 D): |
$0.44 | 4.01%
|
Avg Daily Range (90 D): |
$0.45 | 3.11%
|
Institutional Daily Volume |
Avg Daily Volume: |
.1M |
Avg Daily Volume (30 D): |
.22M |
Avg Daily Volume (90 D): |
.27M |
Trade Size |
Avg Trade Size (Sh.): |
20 |
Avg Trade Size (Sh.) (30 D): |
68 |
Avg Trade Size (Sh.) (90 D): |
66 |
Institutional Trades |
Total Inst.Trades: |
429 |
Avg Inst. Trade: |
$1.77M |
Avg Inst. Trade (30 D): |
$1.13M |
Avg Inst. Trade (90 D): |
$1.2M |
Avg Inst. Trade Volume: |
.03M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$2.06M |
Avg Closing Trade (30 D): |
$7.3M |
Avg Closing Trade (90 D): |
$1.06M |
Avg Closing Volume: |
39.34K |
|
|
|
|
Financials |
|
TTM |
Q3 2024 |
Q2 2024 |
Basic EPS
|
$-4.69
|
$-1.15
|
$-.9
|
Diluted EPS
|
$-4.71
|
$-1.15
|
$-.9
|
Revenue
|
$ -1.72M
|
$ 1.19M
|
$ .91M
|
Gross Profit
|
$
|
$
|
$
|
Net Income / Loss
|
$ -38.7M
|
$ -13.78M
|
$ -10M
|
Operating Income / Loss
|
$ -46.22M
|
$ -15.51M
|
$ -10.99M
|
Cost of Revenue
|
$
|
$
|
$
|
Net Cash Flow
|
$ 8.17M
|
$ -4.26M
|
$ 9.58M
|
PE Ratio
|
|
|
|
Splits |
Feb 14, 2023:
30:1
|
|